Alan Minsk Featured on Scrip M&A Podcast Episode Highlighting Impact of FDA Staff Cuts on Biopharma Dealmaking

AGG Food & Drug practice chair Alan Minsk was recently featured on Citelines’s Scrip M&A Podcast to discuss how reductions in FDA staffing may influence biopharma dealmaking in the coming months. The episode explores industry concerns around regulatory slowdowns amid heightened deal activity and how companies are adapting to these evolving conditions.

During the conversation, Alan offered insight into how staff shortages at FDA could affect timelines for regulatory reviews, due diligence, and product approvals — key elements in the structuring and execution of life sciences transactions. Drawing on his extensive experience advising pharmaceutical and biotechnology clients, Alan addressed potential strategies for mitigating regulatory uncertainty, emphasizing the importance of early engagement with counsel and regulators.

To listen to the full episode, please click here.